These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Management of scleroderma-related end-stage renal disease with automated peritoneal dialysis.
    Author: Pavan M, Aiyangar A, Chaudhari A, Rajputh P, Ranganath R, Babulal SA.
    Journal: Iran J Kidney Dis; 2010 Apr; 4(2):162-3. PubMed ID: 20404430.
    Abstract:
    Kidney failure is the principal cause of death in scleroderma and accounts for at least 50% of deaths in this disease. Management of scleroderma-related end-stage renal disease requires some form of renal replacement therapy. Survival up to 18 months has been reported in one patient on continuous ambulatory peritoneal dialysis. Surviving for more than 1 year on automated peritoneal dialysis has not been reported. We report a patient with scleroderma-related end-stage renal disease treated with automated peritoneal dialysis with steady state control of uremia and hypertension at 18 months of follow-up.
    [Abstract] [Full Text] [Related] [New Search]